Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
Phase 1 Terminated
12 enrolled
Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the Extremities
Phase 1 Terminated
9 enrolled
SADDRIN-1
Phase 1 Terminated
12 enrolled
Nivolumab and Ipilimumab in Treating Patients With HIV Associated Relapsed or Refractory Classical Hodgkin Lymphoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery
Phase 1 Terminated
79 enrolled 24 charts
Dose Escalation and Cohort Expansion Study of Niraparib and Dostarlimab in Paediatric Participants With Solid Tumors (SCOOP)
Phase 1 Terminated
47 enrolled 43 charts
TQB2928 Injection Combined Anlotinib Hydrochloride Capsule in Recurrent/Metastatic Osteosarcoma and Other Solid Tumors
Phase 1 Terminated
20 enrolled
(VELA) Study of BLU-222 in Advanced Solid Tumors
Phase 1 Terminated
50 enrolled
A Study of FAZ053 Single Agent and in Combination With PDR001 in Patients With Advanced Malignancies.
Phase 1 Terminated
154 enrolled
Testing the Ability of AMG 232 (KRT 232) to Get Into the Tumor in Patients With Brain Cancer
Phase 1 Terminated
32 enrolled
A Study of HFB301001 in Adult Patients With Advanced Solid Tumors
Phase 1 Terminated
31 enrolled
A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma
Phase 1 Terminated
25 enrolled
A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors
Phase 1 Terminated
10 enrolled
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Phase 1 Terminated
12 enrolled
Phase Ib Study of TNO155 in Combination With Spartalizumab or Ribociclib in Selected Malignancies
Phase 1 Terminated
122 enrolled
A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours
Phase 1 Terminated
19 enrolled
A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors
Phase 1 Terminated
94 enrolled 28 charts
FAPi Radioligand OpeN-Label, Phase 1 Study to Evaluate Safety, Tolerability and DosImetry of [Lu-177]-PNT6555; A Dose Escalation Study for TReatment of Patients With Select Solid Tumors (FRONTIER)
Phase 1 Terminated
20 enrolled
Temozolomide, Memantine Hydrochloride, Mefloquine, and Metformin Hydrochloride in Treating Patients With Glioblastoma Multiforme After Radiation Therapy
Phase 1 Terminated
144 enrolled
Phase 1a/1b Study of Aplitabart (IGM-8444) Alone or in Combination in Participants with Relapsed, Refractory, or Newly Diagnosed Cancers
Phase 1 Terminated
272 enrolled
FHD-609 in Subjects With Advanced Synovial Sarcoma or Advanced SMARCB1-Loss Tumors
Phase 1 Terminated
55 enrolled
Partial Brain RT, Temozolomide, Chloroquine, and TTF Therapy for the Treatment of Newly Diagnosed Glioblastoma
Phase 1 Terminated
2 enrolled
A Study of NOX66 Plus Doxorubicin in Anthracycline-naïve, Adult Patients With Soft Tissue Sarcoma
Phase 1 Terminated
9 enrolled 10 charts
Master Protocol to Assess Safety and Dose of First Time in Human Next Generation Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Advanced Solid Tumors
Phase 1 Terminated
12 enrolled 12 charts
Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma
Phase 1 Terminated
5 enrolled 16 charts
CAR
Phase 1 Terminated
9 enrolled
CCT301-38 CAR-T in Patients With Relapsed or Refractory AXL Positive Sarcomas
Phase 1 Terminated
9 enrolled
Phase 1, First-in-human Study of Oral TP-1287 in Patients with Advanced Solid Tumors
Phase 1 Terminated
74 enrolled
NT-I7 for Kaposi Sarcoma in Patients With or Without HIV
Phase 1 Terminated
8 enrolled 14 charts
Camsirubicin + Pegfilgrastim to Determine MTD in ASTS
Phase 1 Terminated
14 enrolled
Itacitinib in Treating Patients With Refractory Metastatic/Advanced Sarcomas
Phase 1 Terminated
27 enrolled
Study of PF-07263689 in Participants With Selected Advanced Solid Tumors
Phase 1 Terminated
13 enrolled 16 charts
Sapanisertib Before and After Surgery in Treating Patients With Recurrent Glioblastoma
Phase 1 Terminated
40 enrolled
CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma
Phase 1 Terminated
7 enrolled
DS-6157a in Participants With Advanced Gastrointestinal Stromal Tumor (GIST)
Phase 1 Terminated
34 enrolled 27 charts
Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial Sarcoma
Phase 1 Terminated
12 enrolled
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
Phase 1 Terminated
14 enrolled 20 charts
Temozolomide and Ascorbic Acid in Treating Patients With Recurrent High-Grade Glioma
Phase 1 Terminated
4 enrolled 6 charts
NYESO SCT
Phase 1 Terminated
5 enrolled
A Phase I Study of Lyso-thermosensitive Liposomal Doxorubicin and MR-HIFU for Pediatric Refractory Solid Tumors
Phase 1 Terminated
2 enrolled
NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells)
Phase 1 Terminated
3 enrolled
Trial of Intratumoral Injections of TTI-621 in Subjects With Relapsed and Refractory Solid Tumors and Mycosis Fungoides
Phase 1 Terminated
56 enrolled
ExCeL
Phase 1 Terminated
3 enrolled 8 charts
IBI188 Combination Therapy in Solid Tumors
Phase 1 Terminated
9 enrolled
Safety Study of MGD009 in B7-H3-expressing Tumors
Phase 1 Terminated
67 enrolled
A Study of LY3435151 in Participants With Solid Tumors
Phase 1 Terminated
2 enrolled 8 charts
INTERCEPT
Phase 1 Terminated
2 enrolled
FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue Sarcomas
Phase 1 Terminated
5 enrolled
A Safety Study of SGN-CD47M in Patients With Solid Tumors
Phase 1 Terminated
16 enrolled
Phase 1b Safety Study of CMB305 in Patients With Locally Advanced, Relapsed, or Metastatic Cancer Expressing NY-ESO-1
Phase 1 Terminated
79 enrolled
Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Phase 1 Terminated
10 enrolled